A 70-year-old man presented with an intra-abdominal mass. A contrast-enhanced abdominal CT scanandcontrast-enhancedabdominalMRIshowedafaintlyenhancedlargemassmeasuring5cminthe longest diameter with a well-defined border in the left upper quadrant of abdomen. Pathologically and immunohistologically,thetumorwasdiagnosedasmesentericfibromatosis.Oneyearaftertheresection,a follow-up CT scan showed two well-circumscribed tumors;one in the small bowel mesentery and the other,nearthetransversecolon.Thetumorsweresuspectedtoberecurrencesofmesentericfibromatosisandwereresectedwithapartofthejejunumandtransversecolon,respectively.Thepathologicaldiagnosis was recurrence of mesenteric fibromatosis. One year and 10 months after the re-resection, the patientisalivewithoutrecurrence.Weexperiencedaveryrarecaseofapatientundergoingre-surgery formultiplerecurrentmesentericfibromatosisafterresectionofmesentericfibromatosiswhichdeveloped withouthistoryoffamilialadenomatouspolyposis,surgery,ortrauma.
An 83-year-old man with chronic hepatitis C received interferon therapy, and a sustained virological response (SVR) was achieved 12 years earlier. Three years later, he developed transverse colon cancer and laparoscopic transverse colectomy was performed. However, the serum concentration of CA19-9 was elevated, and positron emission tomography (PET) showed a tumor showing abnormal uptake of 18F-deoxyglucose in the lateral segment of the liver; therefore, the patient was referred to our hospital. The tumor measured 40 mm in diameter and showed peripheral enhancement in the late phase of contrast-enhanced CT. Magnetic resonance cholangiopancreatography revealed stenosis of the left hepatic duct. Therefore, the patient was diagnosed as having intrahepatic cholangiocarcinoma (ICC) with left bile duct invasion, rather than hepatic metastasis from colon cancer, and left hepatectomy was performed. Histopathological and immunohistochemical examinations revealed the tumor as a moderately differentiated ICC. We report a case of ICC that developed 12 years after the patient achieved SVR to interferon therapy administered to treat chronic hepatitis C.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.